Blog Highlights
- Execution gaps are why the Pharma is behind. It is not about science
- The most significant unseen operational risk is visibility lag.
- Siloed systems increase the time it takes to process claims and send out invoices
- Poor execution is what hurts revenue, margins, and DSO.
- Execution can be done predictively with AI enabled platforms
- Projects, resources and finances are integrated.
What is Pharmaceutical Project Management?
Pharma project management is the formal process of planning, executing and controlling drug development programs throughout the entire product life cycle: from drug discovery and development through to regulatory approval and commercial launch.
Unlike standard project management, pharma execution is inherently linked to data tracking, compliance, and regulatory deadlines. A slip-on execution is not merely missing an individual deadline; it can affect regulatory approval, and in turn delay commercialization and cause the revenue stream to be delayed.
The Reality Most Pharma Leaders Don’t See
The reasons that Pharma projects fail, are not scientific. They fail as a result of late signals from execution.
On the face of it, it may seem that control is being maintained. Timelines are set, teams are aligned and projects managed. Underlying this façade is a distributed execution environment, where data resides in disconnected systems, updates are delayed, and risks remain latent until they breach to become major issues.
This results in a lag in visibility; not a deficit of data, but a lack of responsiveness and immediate action on it. Kytes as modern execution platforms, aim to remove the lag in execution signals, across projects, resources and finances, to translate data into instant decisions.
Pharmaceutical Project Lifecycle — Through an Execution Lens
It’s not about knowing the lifecycle-it’s about where execution fails within the lifecycle.
During discovery estimates aren’t based on actual execution, leading to waste later on. Development occurs in silod systems and a lack of coordination can slow progress down to a crawl.
QA and compliance often suffer from scattered documentation and lengthy audits. Regulatory hold ups aren’t about incomplete work, but mismatched or unobtainable data.
Commercialization represents where waste manifests as dollars. Work might get done, but it can take weeks or months to get it billed due to fragmented systems and manual work.
Platforms like Kytes bridge all of these lifecycle stages together into a single flow of execution that ensures a seamless journey from plan to revenue.
The Real Challenges—and Their Business Impact
Familiar problems exist at the heart of pharma organizations and with great consequences.
Lack of resources forces companies to overallocate and be inefficient. Increased complexity of compliance forces manual processes. Data silos and lack of visibility create delayed decision-making and failed milestones.
From a financial point of view, the effect is even more dire. Invoices are delayed, contract interpretation errors are frequent, and timesheets have gaps. This creates a gap between execution and revenue.
Existing tools merely report on activity. They do not link to it.
New PPM Software (such as Kytes) closes this gap between execution and finance by tying it all together.
The Hidden Business Impact of Poor Pharma Execution
The hidden price of a poorly executed job is that it goes unnoticed until it is too late.
Revenue is lost through the failure to bill the job once it’s completed. DSO rises as cash collection falters. Margins shrink through inefficient processes, rework and poor use of resources.
At leadership level, forecasting cannot be accurate as decision-making is based on outdated and fragmented information.
It is not only the delayed job, it is also the delayed revenue.
Kytes provides a solution by tying execution milestones to triggers in the billing system, allowing for cash to flow.
How These Challenges Play Out in Daily Operations
Execution is scattered across nearly all pharma orgs: Planning resides in one system, execution in another, timesheets update days later, QA docs sit elsewhere, and billing waits for manual reconciliation.
This creates a drag, leads to errors, and revenue gets lost in the execution vacuum.
Kytes centralizes the process so real-time execution control can finally happen.
Why Kytes Outperforms Traditional Pharmaceutical Project Management Software
From Fragmentation to Execution Intelligence
What this means:
Execution becomes connected. Revenue becomes predictable. Risks become preventable.
From Fragmentation to Real-Time Execution
How struggling and high-achieving organizations differ is all about design of systems.
Fragmented models are a set of systems that are not integrated, resulting in delays and disconnects. Connected models unite all the functionalities within a single system. Data is transmitted in real time, and execution is linked directly to results.
Kytes operates according to this connected model, where execution, compliance, and financials are integrated into one seamlessly working system.
The Shift to AI-Driven Pharmaceutical Project Management
From the reporting stage, pharma execution is moving into predicting stage.
By identifying risks by using the AI enabled platform such as Kytes by monitoring historic and real time data and allocating resource to its maximum potential.
Leaders receive real time view and hence can make instant decisions, no waiting for the reports, automating billing helps to realize revenue from services rendered.
The pharma execution process has now moved out from reporting stage into prediction stage.
Execution Intelligence: The New Operating Model
Contemporary pharma companies are leveraging an ongoing execution intelligence methodology.
Data is captured, analyzed and risks are predicted based on it, action is taken in real-time with the aim to positively influence outcome, then action fed back into the process.
Kytes delivers this intelligence within the workflow-making execution, a pro-active, data informed process.
From Visibility to Control: A New Execution Standard
The industry is moving past visibility. What they need is control.
Organizations today need systems that can tie together projects, resources, and financials into a single source of truth, providing the visibility they need for real-time billing, reduced DSO, and predictable delivery results.
More importantly, they need to keep it simple. Instead of multiple systems to manage, they need a single toolset that can deliver comprehensive control.
Make your software intelligently simple.
Conclusion
Pharma projects are growing in complexity; the pressure to be compliant, timely, and financially successful is intensifying.
Generic PM tools are failing the challenge; the tools manage and track execution after it occurs, instead of governing it in real-time.
Successful organizations will be the ones that unify the siloed execution process, link the execution to the revenue stream, and harness intelligent and predictive systems (powered by AI).
Kytes is empowering this shift, and moving the discussion from managing project to executing it-intelligently.
Because in Pharma, delivery not development is what matters- on-time, compliant and revenue ready.
Is your business still based on split systems and delayed execute signals? Then it is time to reconsider your process.
See what Kytes can do for your company to achieve high speed delivery and be compliance and in control.
Book a demo and experience execution that’s intelligently simple.
